Page last updated: 2024-11-03

propafenone and Antidiuretic Hormone, Inappropriate Secretion

propafenone has been researched along with Antidiuretic Hormone, Inappropriate Secretion in 2 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rodríguez-Suárez, S1
García-Morillo, S1
Gómez-Morales, L1
Romero-Rodriguez, N1
Beltran-Romero, L1
Gonzalez-Estrada, A1
Dirix, LY1
Moeremans, C1
Fierens, H1
Dielen, D1
Vrints, C1
Van Agt, E1
Snoeck, J1

Other Studies

2 other studies available for propafenone and Antidiuretic Hormone, Inappropriate Secretion

ArticleYear
Variegate porphyria and atrial fibrillation: acute attack induced by propafenone.
    Revista espanola de cardiologia (English ed.), 2012, Volume: 65, Issue:5

    Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Inappropriate ADH Syndrome; Male; Porphy

2012
Symptomatic hyponatremia related to the use of propafenone.
    Acta clinica Belgica, 1988, Volume: 43, Issue:2

    Topics: Aged; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Propafenone; Tachycardia, Atrioventr

1988